Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 3
Efficacy of deoxyspergualine for antibody-mediated rejection and proteinuria after kidney transplantation
Published 6 June 2008 Volume 2008:4(3) Pages 641—644
Hideki Ishida, Kazunari Tanabe
Department of Urology, Tokyo Women’s Medical University, Tokyo, Japan
Abstract: A patient showing antibody-mediated rejection (AMR) with severe vasculitis, and massive proteinuria after kidney transplantation was treated with deoxyspergualine (DSG, Spanidin®, Nippon Kayaku). DSG showed marked efficacy for this patient’s symptoms. We report on a patient for whom DSG was effective against AMR after renal transplantation.
Keywords: deoxyspergualine (DSG), vascular rejection, antihuman leukocyte antigen (HLA) antibody
© 2008 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.